| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1854067-62-1 | (R)-1-[(R)-1-(Di-tert-butylphosphino)ethyl]-2-[2-(di-tertbutylphosphino)phenyl]Ferrocene | C34H52FeP2 |
| 1854067-71-2 | (S)-1-[(S)-1-(Di-tert-butylphosphino)ethyl]-2-[2-(di-tertbutylphosphino)phenyl]Ferrocene | C34H52FeP2 |
| 1855006-12-0 | Regorafenib EP Impurity C | C20H18FN5O3 |
| 1855920-54-5 | 3-chloro Rivaroxaban | C19H18ClN3O5S |
| 1858267-99-8 | 2-[[(3aR,4S,6R,6aS)-6-[7-Amino-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]ethanol | C17H26N6O4S |
| 1858289-64-1 | 4-[1,1'-Biphenyl]-3-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)dibenzothiophene | C30H27BO2S |
| 1859053-21-6 | (1S,4R)-7,7-Dimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulfonic acid compd. with 8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-one (1:1) | C19H18FN3O.C10H16O4S |
| 1859162-80-3 | Sofosbuvir Impurity 93 | C16H20FN2O8P |
| 1860012-45-8 | tert-Butyl N-[(2S,3S)-2-methylpiperidin-3-yl]carbamate | C11H22N2O2 |
| 1860012-52-7 | (3R,5S)-3-Amino-5-methyl-1-piperidinecarboxylic acid 1,1-dimethylethyl ester | C11H22N2O2 |
| 1860793-92-5 | Hexahydro-6-(phenylmethyl)-pyrido[4,3-d]pyrimidine-2,4(1H,3H)-dione | C14H17N3O2 |
| 1860875-51-9 | 4-Chloro-N-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-5-yl]methyl]-$greek945$,$greek945$-difluorobenzeneacetamide | C22H18ClF2N3O4 |
| 1862216-82-7 | Ethyl 9-phenyl-9H-carbazole-3-carboxylate | C21H17NO2 |
| 1863098-74-1 | Cyclopropyl(4,6-dichloropyridin-3-yl)methanonethanone | C9H7Cl2NO |
| 1863930-34-0 | Azilsartan Impurity F | C23H23N3O3 |
| 1864063-95-5 | 1H-Pyrrolo[3,2-c]pyridine-4-carboxylic acid hydrochloride (1:1) | C8H6N2O2.HCl |
| 1864897-67-5 | 2-Hydroxy-N-(pyridin-4-yl)butanamide | C9H12N2O2 |
| 1866059-82-6 | 1,1,2,2-Tetrafluoro-3-methylsulfonylpropane | C4H6F4O2S |
| 1867162-18-2 | 6-Chloro-2-oxo-4-methylchromen-7-yl 4-O-beta-D-xylopyranosyl-beta-D-xylopyranoside | C20H23ClO11 |
| 1868064-50-9 | Abiraterone Acetate 5,6-Epoxide | C26H33NO3 |
| 1868232-32-9 | (R)-N-Cyclohexyl-3-[(3,4-dichlorophenethyl)amino]-N-[2-[[2-hydroxy-2-(3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethyl]amino]ethyl]propanamide | C29H38Cl2N4O4 |
| 1869075-89-7 | Bendamustine USP Related Compound F | C22H33Cl2N3O7 |
| 1869118-24-0 | N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid ethyl ester | C16H16N4O4S |
| 1870821-29-6 | (S)-4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline | C16H14BrCl2N |
| 1870867-59-6 | 4-Cyano-N-[(1,1-dimethylethoxy)carbonyl]-2,6-dimethyl-L-phenylalanine | C17H22N2O4 |
| 1872382-47-2 | N-[4-(1,1-Dimethylethyl)benzoyl]-L-phenylalanyl-L-alanyl-L-leucyl-N6,N6-diethyl-L-lysyl-L-serine methyl ester | C43H66N6O8 |
| 1872435-00-1 | Leuprolide Acetate EP Impurity F | C61H85F3N16O14 |
| 1872440-40-8 | N-[6-[[4-[(3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxobutyl]amino]-1-oxohexyl]-L-alpha-aspartyl-L-alanyl-L-alpha-glutamyl-L-phenylalanyl-L-arginyl-L-histidyl-L-alpha-aspartyl-L-serylglycyl-L-tyrosyl-L-alpha-glutamyl-L-valyl-L-histidyl-L-histidyl-L-glutaminyl-L-lysyl-L-leucyl-L-valyl-L-phenylalanyl-L-phenylalanyl-L-alanyl-L-alpha-glutamyl-L-alpha-aspartyl-L-valylglycyl-L-seryl-L-asparaginyl-L-lysylglycyl-L-alanyl-L-isoleucyl-L-isoleucylglycyl-L-leucyl-L-methionyl-L-valylglycylglycyl-L-valyl-L-valyl-L-isoleucyl-L-alanine | C218H334N58O63S2 |
| 1874218-36-6 | 3-Fluoro-alpha-[1-[(2-hydroxyethyl)amino]ethyl]benzenemethanol | C11H16FNO2 |
| 1874276-76-2 | 3-Amino-N-[3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl]-6-[3-(trifluoromethyl)pyridin-2-yl]pyrazine-2-carboxamide | C22H23F3N8O |
| 1875153-79-9 | Mono-POM Methyl Adefovir | C15H24N5O6P |
| 1876467-74-1 | 2-[(3R)-3-Methyl-4-morpholinyl]-4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-3-yl)-1,7-naphthyridine | C20H21N7O |
| 1878105-23-7 | N-XantPhos Pd G4 | C50H43N2O4P2PdS- |
| 1878109-35-3 | 2-[(2-Hydroxycyclopentyl)oxycarbonylamino]-3,3-dimethylbutanoic acid | C12H21NO5 |
| 1879009-96-7 | Methionine Impurity 1 | C12H22N2O4S2 |
| 1879903-65-7 | Rivaroxaban Oxo Amine Amide Impurity | C19H18ClN3O5S |
| 1882075-20-8 | (11bS)-4-Hydroxy-2,6-bis(2,3,4,5,6-pentafluorophenyl)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide | C32H11F10O4P |
| 1882095-50-2 | 2-(((3aR,4S,6R,6aS)-6-((6-(((3aS,4R,6S,6aS)-6-(2-Hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)amino)-5-nitro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol | C27H43N5O10S |
| 1882095-51-3 | 2-(((3aS,4S,6R,6aS)-6-((5-amino-6-(((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)amino)-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol | C27H45N5O8S |
| 1882873-21-3 | Lenvatinib Impurity 16 | C21H17ClN4O3 |
| 1883265-32-4 | 2-Chloro-4-(1-dibenzofuranyl)-6-phenyl-1,3,5-triazine | C21H12ClN3O |
| 1883265-36-8 | 2-([1,1'-Biphenyl]-3-yl)-4-chloro-6-(dibenzo[b,d]furan-1-yl)-1,3,5-triazine | C27H16ClN3O |
| 1883284-94-3 | 1-[(4-Fluorophenyl)methyl]-1H-indole-3-carboxylic acid 1-naphthalenyl ester | C26H18FNO2 |
| 1883299-62-4 | Brepocitinib | C18H21F2N7O |
| 1883377-30-7 | 8-[4-(2,2-Dimethylpropyl)-2-pyridinyl]-2-(methyl)-benzofuro[2,3-b]pyridine | C22H22N2O |
| 1883423-59-3 | [(2S)-2-(4-Chlorophenyl)-1-pyrrolidinyl](3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl)methanone | C18H17ClN4O |
| 1883429-22-8 | 4-(4-((Dimethylamino)methyl)-2,5-dimethoxyphenyl)-2-methyl-2,7-naphthyridin-1(2H)-one | C20H23N3O3 |
| 1883563-86-7 | Tenofovir Related Compound 8 | C22H40N7O6P |
| 1883595-37-6 | 5-(2-Fluorophenyl)-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-carboxylic acid | C16H11FN2O4S |
| 1883595-38-7 | 5-(2-Fluorophenyl)-1H-pyrrole-3-carboxylic acid | C11H8FNO2 |